Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N E Byars

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical and Experimental Immunology|May 1, 1976
Intestinal anaphylaxis in the rat as a model of food allergyN E Byars, R W Ferraresi
Journal of Medical Primatology|January 1, 1981
Induction of constant sensitivity to dinitrochlorobenzene in the cynomolgus monkeyR W Ferraresi, N E Byars, L D Shott
Vaccine|May 1, 1991
Improvement of hepatitis B vaccine by the use of a new adjuvantN E Byars, G Nakano, M Welch, et al.
Vaccine|February 1, 1990
Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulationN E Byars, A C Allison, M W Harmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1990
Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunityM J Campbell, L Esserman, N E Byars, et al.
International Reviews of Immunology|January 1, 1989
Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumorM J Campbell, L Esserman, N E Byars, et al.
Pharmaceutical Research|September 1, 1989
Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicleD M Lidgate, R C Fu, N E Byars, et al.
Journal of Medical Virology|September 1, 1989
Validation of a first-generation Epstein-Barr virus vaccine preparation suitable for human useA J Morgan, A C Allison, S Finerty, et al.
Journal of Medical Virology|January 1, 1990
Expression of pre-S2 region of hepatitis B surface antigen in Escherichia coliM W Yu, J W Shih, H Bursztyn-Pettegrew, et al.
Vaccine|January 1, 1994
Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infectionN E Byars, E B Fraser-Smith, R A Pecyk, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical and Experimental Immunology|May 1, 1976
Intestinal anaphylaxis in the rat as a model of food allergyN E Byars, R W Ferraresi
Journal of Medical Primatology|January 1, 1981
Induction of constant sensitivity to dinitrochlorobenzene in the cynomolgus monkeyR W Ferraresi, N E Byars, L D Shott
Vaccine|May 1, 1991
Improvement of hepatitis B vaccine by the use of a new adjuvantN E Byars, G Nakano, M Welch, et al.
Vaccine|February 1, 1990
Enhancement of antibody responses to influenza B virus haemagglutinin by use of a new adjuvant formulationN E Byars, A C Allison, M W Harmon, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1990
Idiotype vaccination against murine B cell lymphoma. Humoral and cellular requirements for the full expression of antitumor immunityM J Campbell, L Esserman, N E Byars, et al.
International Reviews of Immunology|January 1, 1989
Development of a new therapeutic approach to B cell malignancy. The induction of immunity by the host against cell surface receptor on the tumorM J Campbell, L Esserman, N E Byars, et al.
Pharmaceutical Research|September 1, 1989
Formulation of vaccine adjuvant muramyldipeptides. 3. Processing optimization, characterization, and bioactivity of an emulsion vehicleD M Lidgate, R C Fu, N E Byars, et al.
Journal of Medical Virology|September 1, 1989
Validation of a first-generation Epstein-Barr virus vaccine preparation suitable for human useA J Morgan, A C Allison, S Finerty, et al.
Journal of Medical Virology|January 1, 1990
Expression of pre-S2 region of hepatitis B surface antigen in Escherichia coliM W Yu, J W Shih, H Bursztyn-Pettegrew, et al.
Vaccine|January 1, 1994
Vaccinating guinea pigs with recombinant glycoprotein D of herpes simplex virus in an efficacious adjuvant formulation elicits protection against vaginal infectionN E Byars, E B Fraser-Smith, R A Pecyk, et al.
Pageof 2